Navigation Links
American College of Medical Genetics receives $13.5M NIH contract
Date:10/8/2008

The American College of Medical Genetics (ACMG), a national nonprofit medical and scientific professional association, announced that it has received a $13.5 million, 5-year contract from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) of the National Institutes of Health (NIH) for the development of a National Newborn Screening Translational Research Network.

"This visionary contract will enable us to improve newborn screening, the care of patients identified in newborn screening, and our knowledge of the conditions that might be added to newborn screening," said Michael S. Watson, PhD, FACMG, executive director of the ACMG.

"At a time when newborn screening is expanding rapidly, this contract from the federal government provides the vehicle for research by the scientific community to study nationwide the most effective ways to introduce new screening tests. We can also assess how best to confirm diagnoses, initiate and follow existing and new treatments and improve their effectiveness, and educate parents and care providers about this growing realm of diagnosing and treating rare genetic disorders in children and giving them the chance to function normally," said Duane Alexander, M.D., Director, NICHD.

The NIH contract, the largest in ACMG history, will fund the establishment of the Newborn Screening Translational Research Network Coordinating Center (NBSTRNCC) whose activities will include, but are not limited to:

  1. Establish an organized network of state newborn screening programs and clinical centers.
  2. Develop, implement and refine a national research informatics system for investigators and policy makers that dovetails with established national clinical networks.
  3. Establish and administer an efficient, reliable repository of residual dried bloodspots that is either virtual or physical and comprised of those stored by state newborn screening programs and other resources.
  4. Facilitate research on screened and treated patients to define effectiveness of treatments and long-term outcomes.
  5. Facilitate research on the development of new methods and technologies.

"By contributing to our understanding of patients with genetic diseases, this contract will accelerate research in diseases related to newborn screening and greatly improve the process by which public health decisions are made about the expansion of newborn screening," said Dr. Watson.

"ACMG is proud to provide leadership for the medical community in the area of newborn screening and in particular translating scientific advances into improved health," said Joe Leigh Simpson, MD, FACMG, president of the ACMG. "This grant is recognition that the optimal treatment of these rare conditions requires collaborative efforts among geneticists and other physicians throughout the nation."


'/>"/>

Contact: Kathy Beal
kbeal@acmg.net
301-238-4582
American College of Medical Genetics
Source:Eurekalert

Related biology news :

1. American Chemical Societys Weekly PressPac
2. Nanotech and synbio: Americans dont know whats coming
3. American Chemical Societys Weekly PressPac -- Sept. 24, 2008
4. News from the October 2008 Journal of the American Dietetic Association
5. American Physical Society announces Physics, a new, free, online publication
6. American Chemical Societys Weekly PressPac -- Sept. 10, 2008
7. New gene variant identified for nondiabetic end stage renal disease in African-Americans
8. Silent streams? Escalating endangerment for North American freshwater fish
9. American Chemical Societys Weekly PressPac -- Sept. 3, 2008
10. African-Americans have unique lung cancer risks from chronic obstructive pulmonary disease
11. NYU, American Museum of Natural History receive $1.6 million NSF grant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2016)... LONDON , April 26, 2016 ... a product subsidiary of Infosys (NYSE: ... to integrate the Onegini mobile security platform with ... http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The integration will ... to access and transact across channels. Using this ...
(Date:4/19/2016)... -- The new GEZE SecuLogic access control ... system solution for all door components. It can be ... interface with integration authorization management system, and thus fulfills ... dimensions of the access control and the optimum integration ... considerable freedom of design with regard to the doors. ...
(Date:4/15/2016)... -- Research and Markets has announced the ...  report to their offering.  ,      ... gait biometrics market is expected to grow at ... Gait analysis generates multiple variables such ... compute factors that are not or cannot be ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
(Date:6/23/2016)... , June, 23, 2016  The Biodesign Challenge (BDC), ... new ways to harness living systems and biotechnology, announced ... (MoMA) in New York City . ... participating students, showcased projects at MoMA,s Celeste Bartos Theater ... Antonelli , MoMA,s senior curator of architecture and design, ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
(Date:6/23/2016)... Prairie, WI (PRWEB) , ... June 23, 2016 ... ... consultancy focused on quality, regulatory and technical consulting, provides a free webinar ... is presented on July 13, 2016 at 12pm CT at no charge. , ...
Breaking Biology Technology: